Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda.
about
Molecular characterisation of drug-resistant Plasmodium falciparum from ThailandArtemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in UgandaMitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsTemporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in UgandaGenetic diversity and chloroquine selective sweeps in Plasmodium falciparumMalaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.Monitoring Plasmodium falciparum growth and development by UV flow cytometry using an optimized Hoechst-thiazole orange staining strategy.Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina FasoA molecular surveillance system for global patterns of drug resistance in imported malariaAnalysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi ArabiaComparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan childrenEvolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South AmericaRapid detection of a molecular marker for chloroquine-resistant falciparum malariaLimited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in UgandaGenetic diversity of Plasmodium falciparum: asexual stages.Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.History, dynamics, and public health importance of malaria parasite resistance.In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from NigeriaImpact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New GuineaMutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, MalaysiaPotential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum.Antimalarial drug therapy: the role of parasite biology and drug resistance.Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal.Prevalence of Plasmodium falciparum pfcrt polymorphisms and in vitro chloroquine sensitivity in Senegal.Optimization of a ligase detection reaction-fluorescent microsphere assay for characterization of resistance-mediating polymorphisms in African samples of Plasmodium falciparum.A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malariaGenetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso.Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.Role of Different Pfcrt and Pfmdr-1 Mutations in Conferring Resistance to Antimalaria Drugs in Plasmodium falciparum.
P2860
Q24799200-25ADAFD6-5D8E-4E86-87B0-D97418FEBD5FQ24815752-9771C0B2-6B4B-4C9A-AF12-786BA9CCE000Q27000750-7AC83473-5C2D-47F1-8926-CB5FCD571D48Q28125904-2627FD81-66CF-4E14-B091-AB3D53155721Q29615117-D67B1296-8919-40DF-9E88-8754C025CC16Q30226671-59BC65FA-374F-466A-B525-A51DFE8563ADQ33321282-E529F3CA-3344-46B9-819D-21A7B3F96433Q33612286-DEED33FF-BCFA-4D68-B841-EF1C2FD9A107Q33676088-45D4E60E-5F5F-40FD-B8FE-F26306C6FC57Q33826359-7245775E-DCB9-4638-A3B1-D001332FB537Q33865549-3BB74408-886F-43D6-AF52-E1FDFDEEFD46Q33918006-DB3E018E-73E0-416A-ABE2-DF407B8129ADQ33947834-89C2EB77-75B1-45FE-A8F1-CFC454C8017EQ33948012-B57521A2-0A20-425A-B706-601F0C791661Q34110766-F64D8439-CDB9-4640-893C-15B8A267EE1FQ34529355-9AD33F70-5F46-46CB-97BC-CBF720A45460Q34631509-3EABD3D6-3A74-4689-A861-4F0B9CDB7B59Q35092092-9D9A8984-4FC4-4111-91FE-E6FD300FAF4AQ35188480-EBA11AE9-E5AE-4BB6-A58F-780DE666E98AQ35545447-8F97F2E9-61B0-4B9C-BE97-EEDF2D96B2C1Q35545461-AE921886-0792-4A83-BABC-AD7C0012ADC5Q35607844-69A12142-0796-4113-91A5-414FF61B7DDBQ35720069-1ABDCC62-14BB-474E-90C4-47AD048EE705Q35768931-60F48F58-F1F9-4D5C-ADE0-CD09BA479003Q35975011-27DC5EC2-C7FA-4383-B133-B0FE193177F1Q36383936-669D7FD9-71D8-43E4-80E1-AF3B40AA3950Q36391717-FA761A63-C4A1-4EAF-83CF-87D18048E696Q36652599-A1CB9C58-6CA3-4A98-A8F5-4A524E210993Q36702998-1875A4B5-6E34-43AF-A5F4-7AD30EDF556BQ36965603-B171DEA7-A717-4825-B53F-CD79DFB05D28Q36971400-C88ED7AC-8CE3-4F4F-9476-77CCE5856242Q37036298-F3BFD4B7-2B6C-4400-88C9-2CF0BA7B62CAQ37190605-30E28FC3-5248-4FA8-AD7E-D336DA9DA091Q37299770-7414B6D3-FCBF-4AFD-9DB3-607BE8613721Q37350124-EBDC1ED8-169E-460E-BB49-E231E2A17FF3Q37436582-83F0E303-7661-4B95-A6F5-EC7F243A0668Q37445582-60DD079E-2D42-443B-BB1F-E04220283A22Q37527013-00FFA1D6-5618-489B-B9C3-D7DABB2F8C43Q37731834-A68F4FBB-9673-44AB-90EF-7E3AFAE579FFQ38288177-C7934FBF-93BB-4745-921B-EEA04B241ADD
P2860
Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Polymorphisms in the Plasmodiu ...... hloroquine in Kampala, Uganda.
@en
type
label
Polymorphisms in the Plasmodiu ...... hloroquine in Kampala, Uganda.
@en
prefLabel
Polymorphisms in the Plasmodiu ...... hloroquine in Kampala, Uganda.
@en
P2093
P921
P356
P1476
Polymorphisms in the Plasmodiu ...... hloroquine in Kampala, Uganda.
@en
P2093
P304
P356
10.1086/319865
P407
P577
2001-03-27T00:00:00Z